Treatment trajectories for <scp>Danish</scp> individuals with type 2 diabetes in the era of emerging glucose‐lowering therapies
Our study documents a trend towards earlier T2D treatment intensification and an increase in the use of GLP-1RAs and SGLT-2is in Denmark. However, optimal T2D treatment is still not received by most individuals with early T2D and established cardiorenal disease.
Authors
- Lotte Rasmussen (ORCID: https://orcid.org/0000-0001-5962-6647)
- Tina Vilsbøll (ORCID: https://orcid.org/0000-0002-0456-6787)
- Jens Søndergaard (ORCID: https://orcid.org/0000-0001-7680-9920)
- Helene Kildegaard (ORCID: https://orcid.org/0000-0003-1930-5851)
- Jacob Harbo Andersen (ORCID: https://orcid.org/0000-0003-0656-6905)
- Reimar W. Thomsen (ORCID: https://orcid.org/0000-0001-9135-3474)
- Anton Pottegård (ORCID: https://orcid.org/0000-0001-9314-5679)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1111/dom.15912
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.79
Funders
- Novo Nordisk
- Syddansk Universitet